Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
Author:
Funder
Natural Science Foundation of Zhejiang Province
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference37 articles.
1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
3. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group;Gusterson;J Clin Oncol,1992
4. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas;Press;J Clin Oncol,1997
5. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group;Andrulis;J Clin Oncol,1998
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NGS mutational status on first diagnostic tissue, liquid biopsy and mastectomy in G2–G3 breast cancer;Romanian Journal of Morphology and Embryology;2024-07-15
2. Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns;Journal of Clinical Pathology;2024-02-12
3. Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level;British Journal of Cancer;2023-09-22
4. PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China;World Journal of Surgical Oncology;2023-09-18
5. Predictors of successful neoadjuvant treatment in HER2‑positive breast cancer;Oncology Letters;2023-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3